Büşra Kaygusuz Aydemir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Büşra Kaygusuz Aydemir has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Sami Güven
Department of Pediatric Neurology, Faculty of Medicine Necmettin Erbakan University Konya Turkey
5 shared publications - Fatma Sargın
Department of Pediatric Neurology, Faculty of Medicine Necmettin Erbakan University Konya Turkey
5 shared publications - Süleyman Şahin
Department of Pediatric Neurology, Faculty of Medicine Necmettin Erbakan University Konya Turkey
5 shared publications - Mehmet Alçı
Necmettin Erbakan University Faculty of Medicine, Department of Pediatric Neurology, Konya, Turkey
4 shared publications - Halil Çelik
Department of Pediatric Neurology, Faculty of Medicine Necmettin Erbakan University Konya Turkey
3 shared publications - Hüseyin Çaksen
Necmettin Erbakan University
3 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (11)
Clinical Spectrum, Outcomes, and Factors Associated With Encephalopathy in Children With Influenza‐Associated Neurological Complications: A Retrospective Cohort Study
Objective: This study aims to characterize the clinical spectrum, outcomes, and factors associated with influenza‐associated encephalopathy in hospitalized children with influenza‐associated neurological complications. Methods: This retrospective cohort study included children younger than 18 years who were hospitalized with laboratory‐confirmed influenza at a tertiary university hospital between 2018 and 2023. We reviewed demographic, clinical, laboratory, neuroimaging, electroencephalographic, cerebrospinal fluid, treatment, and outcome data. Patients with and without encephalopathy were compared, and multivariable logistic regression analysis was performed to identify factors independently associated with influenza‐associated encephalopathy. Results: Among 3040 hospitalized children with laboratory‐confirmed influenza, 115 (3.8%) developed influenza‐associated neurological complications. The median age was 32 months (interquartile range [IQR], 19–58 months), and 67 (58.3%) were male. Influenza A accounted for 80.0% of infections. Seizures were the presenting neurological manifestation in all patients, with generalized tonic–clonic seizures occurring in 101 (87.8%). Encephalopathy and encephalitis were identified in 15 (13.0%) and 11 (9.6%) patients, respectively. Two patients (1.7%) were diagnosed with acute necrotizing encephalopathy (ANE). Most children recovered without permanent neurological deficits; however, one patient developed persistent neurological sequelae and two died during hospitalization. In multivariable analysis, focal seizures (adjusted odds ratio [aOR], 16.98; 95% confidence interval [CI], 3.42–84.27; p = 0.001) and higher lymphocyte counts (aOR, 1.53 per 1000 cells/mm 3 increase; 95% CI, 1.11–2.12; p = 0.009) were independently associated with influenza‐associated encephalopathy. Conclusion: Seizures predominantly characterized influenza‐associated neurological complications in hospitalized children and generally had favorable short‐term outcomes. However, influenza‐associated encephalopathy was associated with substantially greater clinical severity, including prolonged hospitalization, more frequent pediatric intensive care unit admission, and poorer in‐hospital outcomes. Recognition of focal seizures may help identify children who warrant closer assessment for concurrent encephalopathy and timely neurological evaluation.
- 12 November 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (11)
Open AccessClinical Spectrum, Outcomes, and Factors Associated With Encephalopathy in Children With Influenza‐Associated Neurological Complications: A Retrospective Cohort Study
Objective: This study aims to characterize the clinical spectrum, outcomes, and factors associated with influenza‐associated encephalopathy in hospitalized children with influenza‐associated neurological complications. Methods: This retrospective cohort study included children younger than 18 years who were hospitalized with laboratory‐confirmed influenza at a tertiary university hospital between 2018 and 2023. We reviewed demographic, clinical, laboratory, neuroimaging, electroencephalographic, cerebrospinal fluid, treatment, and outcome data. Patients with and without encephalopathy were compared, and multivariable logistic regression analysis was performed to identify factors independently associated with influenza‐associated encephalopathy. Results: Among 3040 hospitalized children with laboratory‐confirmed influenza, 115 (3.8%) developed influenza‐associated neurological complications. The median age was 32 months (interquartile range [IQR], 19–58 months), and 67 (58.3%) were male. Influenza A accounted for 80.0% of infections. Seizures were the presenting neurological manifestation in all patients, with generalized tonic–clonic seizures occurring in 101 (87.8%). Encephalopathy and encephalitis were identified in 15 (13.0%) and 11 (9.6%) patients, respectively. Two patients (1.7%) were diagnosed with acute necrotizing encephalopathy (ANE). Most children recovered without permanent neurological deficits; however, one patient developed persistent neurological sequelae and two died during hospitalization. In multivariable analysis, focal seizures (adjusted odds ratio [aOR], 16.98; 95% confidence interval [CI], 3.42–84.27; p = 0.001) and higher lymphocyte counts (aOR, 1.53 per 1000 cells/mm 3 increase; 95% CI, 1.11–2.12; p = 0.009) were independently associated with influenza‐associated encephalopathy. Conclusion: Seizures predominantly characterized influenza‐associated neurological complications in hospitalized children and generally had favorable short‐term outcomes. However, influenza‐associated encephalopathy was associated with substantially greater clinical severity, including prolonged hospitalization, more frequent pediatric intensive care unit admission, and poorer in‐hospital outcomes. Recognition of focal seizures may help identify children who warrant closer assessment for concurrent encephalopathy and timely neurological evaluation.
- 29 October 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (11) , 1005-1014
Pediatric Leptomeningeal Glial Tumors: A Retrospective Case Series and Review of the Literature
Objective: Diffuse leptomeningeal glioneuronal tumor (DLGNT), including primary diffuse leptomeningeal oligodendroglial tumors (PDLOs) and leptomeningeal spread of high-grade gliomas, are rare pediatric neoplasms with diffuse leptomeningeal dissemination and limited parenchymal involvement. Their often nonspecific neurological symptoms frequently lead to misdiagnosis as infectious or inflammatory meningitis, complicating early identification. Methods: To investigate these diagnostic challenges, the authors retrospectively reviewed the records of 4 pediatric patients (2-13 years) diagnosed with leptomeningeal glial tumors over a 5-year period. Clinical features, neuroimaging, cerebrospinal fluid (CSF) findings, histopathology, treatment, and outcomes were analyzed. Results: All patients had subacute or chronic neurological symptoms, including gait ataxia (4/4), motor weakness (3/4), headache or vomiting (3/4), cognitive or behavioral decline (3/4), and seizures (2/4). Cerebrospinal fluid abnormalities contributed to diagnostic confusion but were not identical across all cases: pleocytosis was present in all patients, elevated protein was documented in those with available protein measurements, and reduced or relatively low glucose was observed only in some patients. Magnetic resonance imaging (MRI) demonstrated diffuse leptomeningeal involvement along the neuraxis in all patients, with cystic/nodular T2-hyperintense lesions and variable enhancement. Three patients were diagnosed within the DLGNT/PDLO spectrum and 1 with high-grade glioma with leptomeningeal dissemination. Hydrocephalus requiring ventriculoperitoneal shunting developed in 3/4 patients. All received chemotherapy; 1 required decompressive spinal surgery and craniospinal radiotherapy. At last follow-up, 3 patients were alive with neurological sequelae and 1 had died of progressive disease. Conclusion: These findings highlight that pediatric leptomeningeal glial tumors are diagnostically challenging and easily mistaken for chronic meningitis. Characteristic MRI findings, elevated CSF protein, and spinal dissemination are important clues.
- 29 October 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (11) , 1005-1014
Pediatric Leptomeningeal Glial Tumors: A Retrospective Case Series and Review of the Literature
Objective: Diffuse leptomeningeal glioneuronal tumor (DLGNT), including primary diffuse leptomeningeal oligodendroglial tumors (PDLOs) and leptomeningeal spread of high-grade gliomas, are rare pediatric neoplasms with diffuse leptomeningeal dissemination and limited parenchymal involvement. Their often nonspecific neurological symptoms frequently lead to misdiagnosis as infectious or inflammatory meningitis, complicating early identification. Methods: To investigate these diagnostic challenges, the authors retrospectively reviewed the records of 4 pediatric patients (2-13 years) diagnosed with leptomeningeal glial tumors over a 5-year period. Clinical features, neuroimaging, cerebrospinal fluid (CSF) findings, histopathology, treatment, and outcomes were analyzed. Results: All patients had subacute or chronic neurological symptoms, including gait ataxia (4/4), motor weakness (3/4), headache or vomiting (3/4), cognitive or behavioral decline (3/4), and seizures (2/4). Cerebrospinal fluid abnormalities contributed to diagnostic confusion but were not identical across all cases: pleocytosis was present in all patients, elevated protein was documented in those with available protein measurements, and reduced or relatively low glucose was observed only in some patients. Magnetic resonance imaging (MRI) demonstrated diffuse leptomeningeal involvement along the neuraxis in all patients, with cystic/nodular T2-hyperintense lesions and variable enhancement. Three patients were diagnosed within the DLGNT/PDLO spectrum and 1 with high-grade glioma with leptomeningeal dissemination. Hydrocephalus requiring ventriculoperitoneal shunting developed in 3/4 patients. All received chemotherapy; 1 required decompressive spinal surgery and craniospinal radiotherapy. At last follow-up, 3 patients were alive with neurological sequelae and 1 had died of progressive disease. Conclusion: These findings highlight that pediatric leptomeningeal glial tumors are diagnostically challenging and easily mistaken for chronic meningitis. Characteristic MRI findings, elevated CSF protein, and spinal dissemination are important clues.
- 20 April 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 180, 45-51
Assessment of the Impact of Social Anxiety on Primary Headache in Adolescents: A Case-Control Study
- 20 April 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 180, 45-51
Assessment of the Impact of Social Anxiety on Primary Headache in Adolescents: A Case-Control Study
- Open Access
- 6 February 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Evaluating the readability, understandability, quality, and popularity of online materials about epilepsy in children
Childhood epilepsy is one of the most common neurological disorders worldwide, significantly affecting cognitive, emotional, and social development. As car
- 6 February 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessEvaluating the readability, understandability, quality, and popularity of online materials about epilepsy in children
Childhood epilepsy is one of the most common neurological disorders worldwide, significantly affecting cognitive, emotional, and social development. As car
- Open Access
- 29 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (2) , 147-151
Evaluation of the Readability and Quality of Online Turkish Materials in the Field of Pediatric Neurology
Objective: Accessible, high-quality online health information is essential for patient under standing, particularly in specialized fields such as pediatric neurology. However, little is known about the readability and quality of Turkish-language online resources in this area. To evaluate the readability and quality of Turkish online educational materials on pediatric neurology using validated readability formulas and standardized quality assessment criteria. Materials and Methods: An Internet-based Patient Educational Material search was con ducted using Google with the terms “çocuk nöroloji” /''child neurology'' and “pediatrik nöroloji”/''pediatric neurology''. After applying exclusion criteria, 69 websites were included. These websites were categorized into 2 groups: Group 1 (academic and hospital websites) and Group 2 (physician and general health information websites). Readability was assessed using the Ateşman and Bezirci-Yılmaz formulas, while website quality was evaluated using the Journal of the American Medical Association (JAMA) benchmark criteria. Results: The median Ateşman Readability Score was 36.63, and the Bezirci-Yılmaz score was 7.04, indicating difficult readability. Only 13.04% of websites met ≥3 JAMA criteria and were classified as high quality. Group 2 (physician and general health information websites) had significantly higher quality scores than Group 1 (academic and hospital websites) (P < .001). No significant differences were found between groups in terms of readability. Conclusion: Most Turkish-language pediatric neurology websites are difficult to read and of low quality. Quality was higher in non-academic sources, although readability remained inadequate across all sources. These findings underscore the need for developing readable and high-quality online educational materials in pediatric neurology to enhance public under standing and informed health decisions.
- 29 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (2) , 147-151
Open AccessEvaluation of the Readability and Quality of Online Turkish Materials in the Field of Pediatric Neurology
Objective: Accessible, high-quality online health information is essential for patient under standing, particularly in specialized fields such as pediatric neurology. However, little is known about the readability and quality of Turkish-language online resources in this area. To evaluate the readability and quality of Turkish online educational materials on pediatric neurology using validated readability formulas and standardized quality assessment criteria. Materials and Methods: An Internet-based Patient Educational Material search was con ducted using Google with the terms “çocuk nöroloji” /''child neurology'' and “pediatrik nöroloji”/''pediatric neurology''. After applying exclusion criteria, 69 websites were included. These websites were categorized into 2 groups: Group 1 (academic and hospital websites) and Group 2 (physician and general health information websites). Readability was assessed using the Ateşman and Bezirci-Yılmaz formulas, while website quality was evaluated using the Journal of the American Medical Association (JAMA) benchmark criteria. Results: The median Ateşman Readability Score was 36.63, and the Bezirci-Yılmaz score was 7.04, indicating difficult readability. Only 13.04% of websites met ≥3 JAMA criteria and were classified as high quality. Group 2 (physician and general health information websites) had significantly higher quality scores than Group 1 (academic and hospital websites) (P < .001). No significant differences were found between groups in terms of readability. Conclusion: Most Turkish-language pediatric neurology websites are difficult to read and of low quality. Quality was higher in non-academic sources, although readability remained inadequate across all sources. These findings underscore the need for developing readable and high-quality online educational materials in pediatric neurology to enhance public under standing and informed health decisions.
- 22 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 33
Diagnostic accuracy of artificial intelligence models in childhood exanthematous diseases: a comparative analysis against clinical diagnosis
Purpose Differentiating among exanthematous diseases is frequently challenging due to their overlapping symptomatology. We, therefore, aimed to evaluate the diagnostic accuracy of a consultant physician, a resident physician, and various AI models (ChatGPT-5, Gemini, Copilot) in this context. Methods We prospectively enrolled 291 patients treated for exanthematous diseases at our clinic between January 2024 and July 2025. The AI models were first tasked with making a diagnosis based solely on cutaneous images and subsequently with both images and accompanying clinical findings. The diagnoses rendered by the consultant, the resident, and the AI models were then compared against the definitive diagnosis. Results When benchmarked against the definitive diagnosis, the consultant achieved the highest diagnostic accuracy (96.6%), followed by ChatGPT (with clinical data, 86.9%), Copilot (with clinical data, 81.4%), Gemini (with clinical data, 78.7%), and the resident physician (72.5%). In contrast, models without clinical data performed poorly, with the lowest accuracy recorded at 30.6% by Copilot. In ROC analysis against the consultant, the resident (AUC: .875) and AI models with clinical data—ChatGPT (AUC: .898), Gemini (AUC: .856), and Copilot (AUC: .818)—all demonstrated good diagnostic power (p < .001). The ChatGPT model without clinical data showed moderate diagnostic power, whereas the Copilot and Gemini models without data were not statistically significant. Performance metrics (sensitivity, specificity) were: ChatGPT (with data) (89.7%, 90.0%); Copilot (with data) (83.6%, 80.0%); Gemini (with data) (81.1%, 90.0%); the resident (75.1%, 100.0%); ChatGPT (no data) (51.6%, 90.0%); Gemini (no data) (33.5%, 100.0%); and Copilot (no data) (31.7%, 100.0%). The consultant's diagnostic performance was significantly superior to all other interpreters and models (p < .001 for all comparisons). Conclusion: This study establishes the diagnostic utility of AI models in pediatric exanthematous diseases, with ChatGPT-5 demonstrating the greatest accuracy when augmented with clinical data. The findings position these models as powerful assistive tools for clinicians but affirm that they do not yet supplant the indispensable expertise of a consultant physician, who remains the gold standard for diagnosis. What is Known: • Overlapping clinical features of exanthematous diseases often lead to diagnostic uncertainty. • Rash-focused artificial intelligence models frequently perform better when supplemented with clinical context rather than image data alone. What is New: • This study provides the first large-scale, multimodal comparison of three next-generation artificial intelligence models (ChatGPT-5, Gemini, Copilot) specifically in pediatric exanthematous diseases. • The study uniquely demonstrates the diagnostic performance gap between image-only and image-plus-clinical-data modes across multiple artificial intelligence models, quantifying the exact improvement provided by clinical context. • By benchmarking artificial intelligence performance simultaneously against both a consultant and a resident physician, this work introduces a novel dual-reference standard, offering more nuanced insight into real-world clinical use cases.
- 22 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 33
Diagnostic accuracy of artificial intelligence models in childhood exanthematous diseases: a comparative analysis against clinical diagnosis
Purpose Differentiating among exanthematous diseases is frequently challenging due to their overlapping symptomatology. We, therefore, aimed to evaluate the diagnostic accuracy of a consultant physician, a resident physician, and various AI models (ChatGPT-5, Gemini, Copilot) in this context. Methods We prospectively enrolled 291 patients treated for exanthematous diseases at our clinic between January 2024 and July 2025. The AI models were first tasked with making a diagnosis based solely on cutaneous images and subsequently with both images and accompanying clinical findings. The diagnoses rendered by the consultant, the resident, and the AI models were then compared against the definitive diagnosis. Results When benchmarked against the definitive diagnosis, the consultant achieved the highest diagnostic accuracy (96.6%), followed by ChatGPT (with clinical data, 86.9%), Copilot (with clinical data, 81.4%), Gemini (with clinical data, 78.7%), and the resident physician (72.5%). In contrast, models without clinical data performed poorly, with the lowest accuracy recorded at 30.6% by Copilot. In ROC analysis against the consultant, the resident (AUC: .875) and AI models with clinical data—ChatGPT (AUC: .898), Gemini (AUC: .856), and Copilot (AUC: .818)—all demonstrated good diagnostic power (p < .001). The ChatGPT model without clinical data showed moderate diagnostic power, whereas the Copilot and Gemini models without data were not statistically significant. Performance metrics (sensitivity, specificity) were: ChatGPT (with data) (89.7%, 90.0%); Copilot (with data) (83.6%, 80.0%); Gemini (with data) (81.1%, 90.0%); the resident (75.1%, 100.0%); ChatGPT (no data) (51.6%, 90.0%); Gemini (no data) (33.5%, 100.0%); and Copilot (no data) (31.7%, 100.0%). The consultant's diagnostic performance was significantly superior to all other interpreters and models (p < .001 for all comparisons). Conclusion: This study establishes the diagnostic utility of AI models in pediatric exanthematous diseases, with ChatGPT-5 demonstrating the greatest accuracy when augmented with clinical data. The findings position these models as powerful assistive tools for clinicians but affirm that they do not yet supplant the indispensable expertise of a consultant physician, who remains the gold standard for diagnosis. What is Known: • Overlapping clinical features of exanthematous diseases often lead to diagnostic uncertainty. • Rash-focused artificial intelligence models frequently perform better when supplemented with clinical context rather than image data alone. What is New: • This study provides the first large-scale, multimodal comparison of three next-generation artificial intelligence models (ChatGPT-5, Gemini, Copilot) specifically in pediatric exanthematous diseases. • The study uniquely demonstrates the diagnostic performance gap between image-only and image-plus-clinical-data modes across multiple artificial intelligence models, quantifying the exact improvement provided by clinical context. • By benchmarking artificial intelligence performance simultaneously against both a consultant and a resident physician, this work introduces a novel dual-reference standard, offering more nuanced insight into real-world clinical use cases.